Broadfin Capital as of June 30, 2019
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 35 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 10.3 | $47M | 1.1M | 43.79 | |
| Iovance Biotherapeutics (IOVA) | 8.3 | $38M | 1.6M | 24.52 | |
| Aratana Therapeutics | 8.2 | $38M | 7.3M | 5.16 | |
| Retrophin | 7.4 | $34M | 1.7M | 20.09 | |
| Nevro (NVRO) | 6.9 | $32M | 488k | 64.83 | |
| Mirati Therapeutics | 4.5 | $21M | 200k | 103.00 | |
| BioDelivery Sciences International | 4.3 | $20M | 4.3M | 4.65 | |
| Allergan | 4.2 | $19M | 115k | 167.43 | |
| Eiger Biopharmaceuticals | 3.8 | $18M | 1.7M | 10.60 | |
| Global Blood Therapeutics In | 3.6 | $17M | 317k | 52.60 | |
| Zogenix | 3.6 | $17M | 345k | 47.78 | |
| Recro Pharma | 3.5 | $16M | 1.6M | 10.17 | |
| Heron Therapeutics (HRTX) | 3.1 | $14M | 758k | 18.59 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.3 | $11M | 2.8M | 3.84 | |
| Dex (DXCM) | 2.1 | $9.5M | 63k | 149.84 | |
| Flamel Technologies Sa | 1.9 | $9.0M | 3.1M | 2.89 | |
| Sientra | 1.9 | $8.6M | 1.4M | 6.16 | |
| La Jolla Pharmaceuticl Com Par | 1.8 | $8.2M | 892k | 9.25 | |
| Strata Skin Sciences | 1.8 | $8.1M | 3.3M | 2.49 | |
| Strongbridge Bioph shs usd | 1.7 | $8.0M | 2.5M | 3.13 | |
| Viewray (VRAYQ) | 1.7 | $7.6M | 867k | 8.81 | |
| Sol Gel Technologies | 1.4 | $6.7M | 730k | 9.11 | |
| Si-bone (SIBN) | 1.4 | $6.4M | 313k | 20.34 | |
| Quotient | 1.3 | $6.0M | 640k | 9.35 | |
| Antares Pharma | 1.2 | $5.7M | 1.7M | 3.29 | |
| Incyte Corporation (INCY) | 1.2 | $5.7M | 67k | 84.95 | |
| Amarin Corporation | 1.2 | $5.6M | 291k | 19.39 | |
| Vericel (VCEL) | 1.1 | $4.9M | 258k | 18.89 | |
| Optinose | 0.9 | $4.2M | 596k | 7.08 | |
| Wright Medical Group Nv | 0.8 | $3.8M | 126k | 29.82 | |
| Myriad Genetics (MYGN) | 0.8 | $3.4M | 124k | 27.78 | |
| Adma Biologics (ADMA) | 0.6 | $2.9M | 748k | 3.87 | |
| Adamas Pharmaceuticals | 0.6 | $2.7M | 441k | 6.20 | |
| Nanostring Technologies (NSTGQ) | 0.5 | $2.3M | 75k | 30.35 | |
| Matinas Biopharma Holdings, In | 0.1 | $659k | 767k | 0.86 |
